BIOELISA HIV 1+2 AG/AB
Mexico·Clase II·III. DIAGNOSTIC AGENTS·I.L. DIAGNOSTICS, S.A. DE C.V.·Registered February 05, 2020PRUEBA ELISA PARA LA DETECCIÓN DEANTICUERPOS FRENTE A LOS VIRUS DE LAINMUNODEFICIENCIAHUMANA(HIV)DETIPO1(GRUPOM-O)ODETIPO2YANTÍGENOSP24DELHIV EN MUESTRAS HUMANAS DE SUERO OPLASMA.
ELISA TEST FOR THE DETECTION OF ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUSES (HIV) TYPE 1 (GROUPM-O) ODETYPE2YANTÍGENOSP24DELHIV IN HUMAN SERUM OR PLASMA SAMPLES.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETECCIÓN DEANTICUERPOSANTI-HIV-1YANTI-HIV-2 Y ANTÍGENO P24 DEL HIV
- Trade Name (English)
- REAGENT FOR THE DETECTION OFANTIBODIESANTI-HIV-1YANTI-HIV-2 AND HIV P24 ANTIGEN
- Analysis ID
- 73R2020 SSA
- Registration Date
- February 05, 2020
- Name (Spanish)
- I.L. DIAGNOSTICS, S.A. DE C.V.
- Name (English)
- I.L. DIAGNOSTICS, S.A. DE C.V.
Access comprehensive regulatory information for BIOELISA HIV 1+2 AG/AB (BIOELISA HIV 1+2 AG/AB) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 73R2020 SSA and manufactured by I.L. DIAGNOSTICS, S.A. DE C.V.. The device was registered on February 05, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.